| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Roivant Sciences Ltd.'s insiders have reduced their positions by a net 4,914,489 shares worth roughly $168.8M. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. ROIV sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 113.32M | $4.08B | - | |
| 10% | 34.49M | $1.24B | - | |
| Pres | 18.68M | $673.05M | - | |
| CEO | 16.74M | $603.09M | - | |
| Dir | 13.69M | $493.29M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | Venker Eric | President &COO | Sale+OE | 100,000 | $10.95 | $1,095,000.00 | -8.5% | +7.0% | +193.6% | |
| May 7, 2025 | Ramaswamy Vivek | 10% Owner | Sell | 898,959 | $11.27 | $10,129,809.73 | -1.1% | +4.1% | +153.2% | |
| Apr 21, 2025 | Venker Eric | President &COO | Sale+OE | 100,000 | $10.22 | $1,022,000.00 | -8.2% | +14.3% | - | |
| Mar 24, 2025 | Venker Eric | President &COO | Sale+OE | 750,000 | $10.92 | $8,190,725.28 | -26.4% | +6.2% | +148.1% | |
| Feb 20, 2025 | Venker Eric | President &COO | Sale+OE | 100,000 | $10.65 | $1,065,000.00 | -10.0% | +1.8% | +153.3% | |
| Feb 13, 2025 | Kumar Rakhi45 | Chief Accounting Officer | Sale+OE | 227,500 | $10.43 | $2,372,825.00 | -58.2% | +2.1% | +153.1% | |
| Feb 13, 2025 | Venker Eric | President &COO | Sale+OE | 435,425 | $10.47 | $4,561,040.74 | -21.1% | +2.1% | +153.1% | |
| Jan 21, 2025 | Venker Eric | President &COO | Sale+OE | 100,000 | $11.28 | $1,128,000.00 | -12.0% | -10.9% | +103.9% | |
| Jan 13, 2025 | Roivant Sciences Ltd.78 | Director, 10% Owner | Buy | 16,845,010 | $20.00 | $336,900,200.00 | +21.1% | -5.1% | +118.2% | |
| Dec 30, 2024 | Venker Eric | President &COO | Sale+OE | 354,604 | $11.68 | $4,141,662.16 | -20.1% | -11.7% | +89.2% |